Please find below an overview of our research projects.


PHOREVER stands for “PHOtonic integrated OCT-enhanced flow cytometry for canceR and cardiovascular diagnostics enabled by Extracellular VEsicles discRimination” and is a research and innovation action that aims to develop a disruptive multi-sensing platform with a great medical impact. The platform will enable for the first time the reliable detection of EVs with size down to 80 nm, the detection of EVs with specific biomarkers (proteins) on their surface, and the calculation of the corresponding EV concentrations in the blood while data analysis empowered by artificial intelligence will correlate the measurement data to disease specific medical information.